Trial quantifies quality-of-life, cost benefits of FFR-guided PCI

10/29/2012 | TheHeart.org (Montreal)

Fractional flow reserve-guided percutaneous coronary intervention is cost-effective and improves quality of life when compared with medical management in stable patients who have flow-limiting coronary lesions, according to results from the FAME II trial. Researchers found similar outcomes for rates of mortality and myocardial infarction but a significantly lower rate of urgent revascularization at the two-year mark for PCI patients.

View Full Article in:

TheHeart.org (Montreal)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director Medical Affairs
Edwards Lifesciences
Irvine, CA
Senior Scientist - Cell Engineering Group
Pfizer
San Francisco, CA
Medical Director - Physician
Willamette Valley Community Health
Salem, OR
Area Reimbursement Manager (CT, MA, MD, ME, NH, NJ, NY, PA, VT)
SI-BONE, INC
Multiple Locations, SL_Multiple Locations
Medical Director - Physician
Willamette Valley Community Health
Salem, OR